Business · 03/08/2006Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for CLINACOX Patent Extension
Summary
The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for CLINACOX, a patent extension application submitted to the Department of Commerce, and is publishing this official notice as required by law.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →